| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |